The FDA has set a goal date of Aug. 27, 2025. If approved, the therapy would be branded as Lytenava and be the first ...

Government has allocated A$180,000 ($108,079) to improve treatment and support for individuals affected by macular disease.

I'm hoping that a softer approach to these 40 days will help prepare me for the more difficult ones I know are coming.

Our team has worked diligently to advance our development and regulatory strategies for ONS-5010 to get to this point and we are proud of the continued progress we have been able to achieve,” ...

William Blair initiated coverage of Ocular Therapeutix (OCUL) with an Outperform rating and fair value of $18 per share. Ocular is a commercial ...

In an era dominated by screens, where we spend countless hours glued to our devices, maintaining optimal eye health has never ...

Discover the warning signs and treatment options for myopic macular degeneration, a serious eye condition affecting people ...

Ophthalmologists specialize in wet AMD diagnosis and treatment. Learn about first steps toward diagnosis and treatment.

Medically reviewed by Christine L. Larsen, MD Myopic macular degeneration (MMD), or pathological myopia, occurs when high ...

A new study led by Brigham and Women’s Hospital has found that taking cocoa flavanol supplements does not significantly reduce the risk of developing age-related macular degeneration (AMD), a leading ...

and eye imaging results to better understand the causes of dry age-related macular degeneration (dry AMD), a leading cause of vision loss. This approach led the biotech to the in-house discovery ...

Bryan Wolynski, a board-certified optometrist, discusses what patients should know before their first appointment for ...